Small Cap Bullish Stocks: CONN’S, Inc. (NASDAQ:CONN), Synta Pharmaceuticals Corp. (NASDAQ:SNTA), ReneSola (NYSE:SOL), Horizon Pharma Inc. (NASDAQ:HZNP)

Posted by on Apr 23, 2014

Texas-based Conn’s Inc. (NASDAQ:CONN) will open a Conn’s Home Plus on May 10 in 42,296 square feet formerly occupied by Babies “R” Us in the Cross Creek Shopping Center at Riverdale and Route 385. CONN’S, Inc. (NASDAQ:CONN) shares after opening at $43.60 moved to $48.37 on last trade day and at the end of the day closed at $46.98. Company price to sales ratio in past twelve months was calculated as 1.42 and price to cash ratio as 297.87. CONN’S, Inc. (NASDAQ:CONN) showed a positive weekly performance of 18.31%.

On April 11, 2014, Synta Pharmaceuticals Corp. (NASDAQ:SNTA) entered into a Subscription Agreement with KFO Holdings LLC, an entity affiliated with Bruce Kovner. Synta Pharmaceuticals Corp. (NASDAQ:SNTA) shares advanced 9.48% in last trading session and ended the day on $4.39. SNTA return on equity ratio is recorded as -231.70% and its return on assets is -112.90%. Synta Pharmaceuticals Corp. (NASDAQ:SNTA) yearly performance is -53.05%.

ReneSola Ltd. (ADR) (NYSE:SOL) intends to gain despite the lukewarm solar module in the first quarter, because of the ongoing emphasis on increased carbon emissions, climate change as well as environmental causes. ReneSola Ltd. (ADR) (NYSE:SOL) shares moved up 7.46% in last trading session and was closed at $3.17, while trading in range of $2.93 – $3.17. ReneSola Ltd. (ADR) (NYSE:SOL) year to date (YTD) performance is -8.12%.

Horizon Pharma, Inc. (NASDAQ:HZNP) on 17 April announced the appointment of H. Thomas Watkins, former director, president and chief executive officer of Human Genome Sciences, to its board of directors. Additionally, Jean-François Formela, M.D. has resigned from the Horizon board of directors. Horizon Pharma Inc. (NASDAQ:HZNP) weekly performance is 17.70%. On last trading day company shares ended up $14.76. Horizon Pharma Inc. (NASDAQ:HZNP) distance from 50-day simple moving average (SMA50) is 11.61%. Analysts mean target price for the company is $22.20.

Leave a Reply

Your email address will not be published. Required fields are marked *